Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2020

05.02.2020 | Review Article

Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties

verfasst von: Elisa Pareja-Martínez, Elisabeth Esquivel-Prados, Fernando Martínez-Martínez, José P. García-Corpas

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background Non-adherence to antihypertensive treatment is currently considered one of the most significant risk factors in failure to achieve controlled blood pressure values. It is therefore extremely important to measure patient adherence to antihypertensive treatment. One way to measure adherence is through questionnaires. Numerous questionnaires for measuring adherence to antihypertensive treatment have been validated, but it not easy to choose one of them as being more appropriate than all of the others. Aim of the review The aim of this study was to identify and assess questionnaires designed to measure non-adherence to antihypertensive treatment, and to discuss their psychometric properties. Method A systematic review of the literature contained in PubMed and Scopus databases was undertaken to identify validated questionnaires on adherence to antihypertensive treatment up to October 2017. PRISMA guidelines were followed to conduct and report this review. Selection of articles and data extraction were performed by two independent researchers. When there was lack of agreement, a third researcher mediated in the discussion between the first two authors so that consensus could be reached. Results 39 articles were obtained containing 17 different questionnaires for measuring adherence to antihypertensive treatment. These questionnaires were validated in 15 countries. The number of items in the questionnaires ranged from three in QAM-Q to 33 in TAQPH. Hill-Bone compliance to high blood pressure therapy scale, Morisky-Green-Levine test and an 8-item Self-Reported Medication Adherence Measurement were the most widely validated questionnaires. Validity was analyzed more than reliability. Many of the questionnaires do not provide information on content validity. Construct validity and concurrent validity are analyzed in almost all of the questionnaires, and give highly variable results. By contrast, known-groups validity was not analyzed to any great degree. As regards reliability, almost all of the questionnaires provided Cronbach’s alpha information with reasonably acceptable results, but temporal stability was not analyzed to any great degree. Conclusion None of the questionnaires included in the review demonstrates fulfilling all of the validity tests (content validity, construct validity and criterion-related validity) and reliability tests (homogeneity and temporal stability) in an acceptable manner. Therefore, none of them can be considered a Gold Standard.
Literatur
1.
Zurück zum Zitat NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet Lond Engl. 2017;389:37–55. NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet Lond Engl. 2017;389:37–55.
3.
Zurück zum Zitat Patricia MK, Megan W, Kristi R, Paul KW, Jiang H. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–9. Patricia MK, Megan W, Kristi R, Paul KW, Jiang H. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–9.
4.
Zurück zum Zitat Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3104-3021. Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3104-3021.
5.
Zurück zum Zitat Costa F. Improving adherence to treatment and reducing economic costs of hypertension: the role of olmesartan-based treatment. High Blood Press Cardiovasc Prev. 2017;24:265–74.PubMed Costa F. Improving adherence to treatment and reducing economic costs of hypertension: the role of olmesartan-based treatment. High Blood Press Cardiovasc Prev. 2017;24:265–74.PubMed
6.
Zurück zum Zitat Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36:55–69.PubMed Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36:55–69.PubMed
7.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6:e1000097.PubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6:e1000097.PubMedPubMedCentral
8.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedPubMedCentral
9.
Zurück zum Zitat Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.PubMed Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.PubMed
10.
Zurück zum Zitat Krousel-Wood M, Jannu A, Re RN, Muntner P, Desalvo K. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128–33.PubMed Krousel-Wood M, Jannu A, Re RN, Muntner P, Desalvo K. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128–33.PubMed
11.
Zurück zum Zitat Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.PubMed Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.PubMed
12.
Zurück zum Zitat Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15:207–11.PubMed Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15:207–11.PubMed
13.
Zurück zum Zitat Song Y, Han H-R, Song H-J, Nam S, Nguyen T, Kim MT. Psychometric evaluation of Hill-Bone medication adherence subscale. Asian Nurs Res. 2011;5:183–8. Song Y, Han H-R, Song H-J, Nam S, Nguyen T, Kim MT. Psychometric evaluation of Hill-Bone medication adherence subscale. Asian Nurs Res. 2011;5:183–8.
14.
Zurück zum Zitat Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the Polish adaptation of the Hill-Bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16:87.PubMed Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the Polish adaptation of the Hill-Bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16:87.PubMed
15.
Zurück zum Zitat Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMed Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMed
16.
Zurück zum Zitat van de Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract. 2009;15:468–72.PubMed van de Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract. 2009;15:468–72.PubMed
17.
Zurück zum Zitat Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky–Green test to evaluate medication adherence. Rev Saude Publica. 2012;46:279–89.PubMed Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky–Green test to evaluate medication adherence. Rev Saude Publica. 2012;46:279–89.PubMed
18.
Zurück zum Zitat Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54.
19.
Zurück zum Zitat Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, de Lyra Junior DP. Association between the 8-item Morisky medication adherence scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99:649–58.PubMed Oliveira-Filho AD, Barreto-Filho JA, Neves SJF, de Lyra Junior DP. Association between the 8-item Morisky medication adherence scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99:649–58.PubMed
20.
Zurück zum Zitat Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin P-F, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens Greenwich Conn. 2012;14:429–34. Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin P-F, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens Greenwich Conn. 2012;14:429–34.
21.
Zurück zum Zitat Shin D-S, Kim C-J. Psychometric evaluation of a Korean version of the 8-item medication adherence scale in rural older adults with hypertension. Aust J Rural Health. 2013;21:336–42.PubMed Shin D-S, Kim C-J. Psychometric evaluation of a Korean version of the 8-item medication adherence scale in rural older adults with hypertension. Aust J Rural Health. 2013;21:336–42.PubMed
22.
Zurück zum Zitat de Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, de Lyra DP. The 8-item Morisky Medication adherence scale: validation of a Brazilian–Portuguese version in hypertensive adults. Res Soc Adm Pharm. 2014;10:554–61. de Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, de Lyra DP. The 8-item Morisky Medication adherence scale: validation of a Brazilian–Portuguese version in hypertensive adults. Res Soc Adm Pharm. 2014;10:554–61.
23.
Zurück zum Zitat Kim J-H, Lee W-Y, Hong Y-P, Ryu W-S, Lee KJ, Lee W-S, et al. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea. J Epidemiol. 2014;24:132–40.PubMedPubMedCentral Kim J-H, Lee W-Y, Hong Y-P, Ryu W-S, Lee KJ, Lee W-S, et al. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea. J Epidemiol. 2014;24:132–40.PubMedPubMedCentral
24.
Zurück zum Zitat Hacıhasanoğlu Aşılar R, Gözüm S, Çapık C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2014;14:692–700. Hacıhasanoğlu Aşılar R, Gözüm S, Çapık C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2014;14:692–700.
25.
Zurück zum Zitat Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7:173–83.PubMed Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7:173–83.PubMed
26.
Zurück zum Zitat Pareja-Martínez E, Esquivel-Prados E, Franco L, García-Corpas JP. Adherence to antihypertensive therapy in community pharmacy: evaluating the psychometric properties of the Morisky medication adherence scale (MMAS-8) translated into Spanish. Pilot study. Lat Am J Pharm. 2015;34:86–93. Pareja-Martínez E, Esquivel-Prados E, Franco L, García-Corpas JP. Adherence to antihypertensive therapy in community pharmacy: evaluating the psychometric properties of the Morisky medication adherence scale (MMAS-8) translated into Spanish. Pilot study. Lat Am J Pharm. 2015;34:86–93.
27.
Zurück zum Zitat Gallagher BD, Muntner P, Moise N, Lin JJ, Kronish IM. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens. 2015;33:1108–13.PubMedPubMedCentral Gallagher BD, Muntner P, Moise N, Lin JJ, Kronish IM. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens. 2015;33:1108–13.PubMedPubMedCentral
28.
Zurück zum Zitat Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens JASH. 2015;9(420–426):e2. Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens JASH. 2015;9(420–426):e2.
29.
Zurück zum Zitat Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS ONE. 2016;11:e0158499.PubMedPubMedCentral Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS ONE. 2016;11:e0158499.PubMedPubMedCentral
30.
Zurück zum Zitat Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the Polish version of the eight-item Morisky medication adherence scale in hypertensive adults. Patient Prefer Adherence. 2016;10:1759–66.PubMedPubMedCentral Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the Polish version of the eight-item Morisky medication adherence scale in hypertensive adults. Patient Prefer Adherence. 2016;10:1759–66.PubMedPubMedCentral
31.
Zurück zum Zitat Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African–American patients. J Clin Epidemiol. 2003;56:520–9.PubMed Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African–American patients. J Clin Epidemiol. 2003;56:520–9.PubMed
32.
Zurück zum Zitat Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31:453–62.PubMedPubMedCentral Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31:453–62.PubMedPubMedCentral
33.
Zurück zum Zitat Gozum S, Hacihasanoglu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. Eur J Cardiovasc Nurs J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2009;8:129–36. Gozum S, Hacihasanoglu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. Eur J Cardiovasc Nurs J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2009;8:129–36.
34.
Zurück zum Zitat Hacihasanoğlu R, Gözüm S, Capik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2012;12:241–8. Hacihasanoğlu R, Gözüm S, Capik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2012;12:241–8.
35.
Zurück zum Zitat Saffari M, Zeidi IM, Fridlund B, Chen H, Pakpour AH. A Persian adaptation of medication adherence self-efficacy scale (MASES) in hypertensive patients: psychometric properties and factor structure. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2015;22:247–55. Saffari M, Zeidi IM, Fridlund B, Chen H, Pakpour AH. A Persian adaptation of medication adherence self-efficacy scale (MASES) in hypertensive patients: psychometric properties and factor structure. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2015;22:247–55.
36.
Zurück zum Zitat Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the treatment adherence questionnaire for patients with hypertension. J Adv Nurs. 2012;68:1402–13.PubMed Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the treatment adherence questionnaire for patients with hypertension. J Adv Nurs. 2012;68:1402–13.PubMed
37.
Zurück zum Zitat Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12:76–86.PubMed Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12:76–86.PubMed
38.
Zurück zum Zitat de Santa Helena ET, Nemes MIB, Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing non-adherence to medicines. Rev Saude Publica. 2008;42:764–7.PubMed de Santa Helena ET, Nemes MIB, Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing non-adherence to medicines. Rev Saude Publica. 2008;42:764–7.PubMed
39.
Zurück zum Zitat Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282–8.PubMed Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282–8.PubMed
40.
Zurück zum Zitat Pérez-Escamilla B, Franco-Trigo L, Moullin JC, Martínez-Martínez F, García-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569–78.PubMedPubMedCentral Pérez-Escamilla B, Franco-Trigo L, Moullin JC, Martínez-Martínez F, García-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569–78.PubMedPubMedCentral
42.
Zurück zum Zitat Martínez JW, Villa Perea JA, Jaramillo J, Quintero Betancur AM, Calderón V. Validación del cuestionario de adherencia al tratamiento anti hipertensivo Martín Bayarré Grau. Rev Med Risaralda. 2011;17:101–5. Martínez JW, Villa Perea JA, Jaramillo J, Quintero Betancur AM, Calderón V. Validación del cuestionario de adherencia al tratamiento anti hipertensivo Martín Bayarré Grau. Rev Med Risaralda. 2011;17:101–5.
43.
Zurück zum Zitat Strainer DL, Norman GR, Cairney J. Health measurement scales. A practical guide to their development and use. 5th ed. Oxford: Oxford University Press; 2015. Strainer DL, Norman GR, Cairney J. Health measurement scales. A practical guide to their development and use. 5th ed. Oxford: Oxford University Press; 2015.
44.
Zurück zum Zitat DeVellis RF. Scale development. Theory and applications. 3rd ed. California: Sage Publication; 2012. DeVellis RF. Scale development. Theory and applications. 3rd ed. California: Sage Publication; 2012.
45.
Zurück zum Zitat Powell KR, Peterson SR. Coverage and quality: a comparison of web of science and scopus databases for reporting faculty nursing publication metrics. Nurs Outlook. 2017;65:572–8.PubMed Powell KR, Peterson SR. Coverage and quality: a comparison of web of science and scopus databases for reporting faculty nursing publication metrics. Nurs Outlook. 2017;65:572–8.PubMed
46.
Zurück zum Zitat Johnson MJ, Rogers S. Development of the purposeful action medication-taking questionnaire. West J Nurs Res. 2006;28:335–51.PubMed Johnson MJ, Rogers S. Development of the purposeful action medication-taking questionnaire. West J Nurs Res. 2006;28:335–51.PubMed
47.
Zurück zum Zitat Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: development and validation of the «Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire». Patient Educ Couns. 2006;64:151–8.PubMed Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: development and validation of the «Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire». Patient Educ Couns. 2006;64:151–8.PubMed
48.
Zurück zum Zitat He W, Bonner A, Anderson D. Patient reported adherence to hypertension treatment: A revalidation study. Eur J Cardiovasc Nurs. 2016;15:150–6.PubMed He W, Bonner A, Anderson D. Patient reported adherence to hypertension treatment: A revalidation study. Eur J Cardiovasc Nurs. 2016;15:150–6.PubMed
Metadaten
Titel
Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties
verfasst von
Elisa Pareja-Martínez
Elisabeth Esquivel-Prados
Fernando Martínez-Martínez
José P. García-Corpas
Publikationsdatum
05.02.2020
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2020
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-00981-x

Weitere Artikel der Ausgabe 2/2020

International Journal of Clinical Pharmacy 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.